| Adverse events | |||
|---|---|---|---|
| Study | Group ‐ within‐participant study | Event number | Total number of pairs of hands analysed |
| At least 1 adverse event | |||
| Möller 1983 | Clobetasol | 4 | 46 |
| Möller 1983 | Flupredniden | 3 | 46 |
| Burning sensation | |||
| Möller 1983 | Clobetasol | 2 | 46 |
| Möller 1983 | Flupredniden | 2 | 46 |
| Reversible atrophy | |||
| Möller 1983 | Clobetasol | 1 | 46 |
| Möller 1983 | Flupredniden | 0 | 46 |
| Brittle skin | |||
| Möller 1983 | Clobetasol | 1 | 46 |
| Möller 1983 | Flupredniden | 1 | 46 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.